gtucker8585

[TimAlerts] $INVA - Innoviva and GlaxoSmithKline (GSK) report positive top-line results from the pivotal phase III FULFIL study; shows superiority of closed triple combination therapy FF/UMEC/VI versus Symbicort Turbohaler

Page
of 1